A data-fueled framework for sponsors and CROs in navigating this shifting terrain.
Samir Shah
Advertisement
President, Strategic Solutions, ICON
Articles by Samir Shah
Can full-service outsourcing to CROs by large biopharma companies sustainably prosecute a clinical development portfolio?
Differentiating FSO and FSP approaches can better align definitions of models for CROs and sponsors.
Advertisement
Latest Updated Articles
Anticipating Near-Term Structural Change in the Outsourcing LandscapePublished: December 22nd 2023 | Updated:
The Strategic Emergence of Site Networks in Clinical ResearchPublished: October 14th 2024 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
